| Home | Help | Search/Archive | Feedback | Table of Contents |
Pill could reduce cardiovascular disease considerably
Measure cholesterol in everyone over 50
Paperless records are better than traditional system
Scottish hospital consultants deprecate on-call workload
Genetic epidemiology can help control Chagas' disease in Latin America
blocker, an angiotensin converting enzyme
inhibitor, folic acid, and aspirin simultaneously reduces four key
cardiovascular risk factors: low density lipoprotein cholesterol, blood
pressure, serum homocysteine, and platelet function. The authors' systematic
review and meta-analysis of over 200 studies
(p 1423) shows that
the use of statins can lower low density lipoprotein cholesterol by 1.8
mmol/l, which could decrease the risk of ischaemic heart disease by 60% and
stroke by 17%. Their examination of 354 randomised controlled trials
(p 1427) found that
giving drugs at half the standard dose can significantly lower blood pressure
with minimal adverse effects, which in turn reduces the risk of stroke by 63%
and ischaemic heart disease by 46%. In an accompanying editorial, Rodgers
(p 1407) says that
the Polypill may have enormous potential for preventing cardiovascular
disease, including in developing
countries.
|
|
|
|
| Home | Help | Search/Archive | Feedback | Table of Contents |